Yongzhuo Huang
{'en': 'Email: yzhuangATmail.shcnc.ac.cn\\nPhone: 021-20231000-1401', 'zh': '电子邮件:yzhuangATmail.shcnc.ac.cn\\n联系电话:021-20231000-1401', 'de': 'E-Mail: yzhuangATmail.shcnc.ac.cn\\nTelefon: 021-20231000-1401'}
English, Chinese
Shanghai
University of Chinese Academy of Sciences
Medical School
  • Zhejiang University - Graduate
  • Zhejiang University - Doctorate
  • 2008-2010 Senior Research Fellow, University of Michigan College of Pharmacy
  • 2005-2008 Research Fellow, University of Michigan College of Pharmacy
  • 2010 - Present - Chinese Academy of Sciences Shanghai Institute of Materia Medica - Researcher, Group Leader
Transdermal New Formulations and Technologies
Biotechnology Drug Delivery Systems
Environmentally Responsive Tumor Molecular Probes and Imaging
  • Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis, Tang, Yisi, Liang, Jianming, Wu, Aihua, Chen, Yingzhi, Zhao, Pengfei, Lin, Tingting, Zhang, Meng, Xu, Qin, Wang, Jianxin, Huang, Yongzhuo, 2020
  • Improved Protein Toxin Delivery Based on ATTEMPTS Systems, Chen, Yingzhi, Zhang, Meng, Min, Kyoung Ah, Wang, Huiyuan, Shin, Meong Cheol, Li, Feng, Yang, Victor C, Huang, Yongzhuo, 2018
  • Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites, Xu, Fan, Zhong, Huihai, Chang, Ya, Li, Dongdong, Jin, Hongyue, Zhang, Meng, Wang, Huiyuan, Jiang, Chen, Shen, Youqing, Huang, Yongzhuo, 2018
  • Dual-Targeting Biomimetic Delivery for Antiglioma via Remodeling Tumor Microenvironment and Directing Macrophage-Mediated Immunotherapy, Yongzhuo Huang, 2018
  • Liposomal Codelivery of Doxorubicin and Andrographolide Inhibits Breast Cancer Growth and Metastasis, Kang, Xuejia, Zheng, Zenin, Liu, Zehua, Wang, Huiyuan, Zhao, Yuge, Zhang, Wenyuan, Shi, Mingjie, He, Yang, Cao, Yang, Xu, Qin, Peng, Chengyuan, Huang, Yongzhuo, 2018
  • Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation, Li, Dongdong, Zhang, Meng, Xu, Fan, Chen, Yingzhi, Chen, Binfan, Chang, Ya, Zhong, Huihai, Jin, Hongyue, Huang, Yongzhuo, 2018
  • Mannosylated Liposomal Codelivery of Dihydroartemisinin and Doxorubicin for Drug-Resistant Colon Cancer Therapy, Yongzhuo Huang, 2017
  • Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery, Chen, Yingzhi, Zhang, Meng, Jin, Hongyue, Li, Dongdong, Xu, Fan, Wu, Aihua, Wang, Jinyu, Huang, Yongzhuo, 2017
  • Microneedle-Assisted, DC-Targeted Codelivery of pTRP-2 and Adjuvant of Paclitaxel for Transcutaneous Immunotherapy, Xu, Jiaojiao, Xu, Beihua, Tao, Jin, Yang, Yunxu, Hu, Ying, Huang, Yongzhuo, 2017
  • Reprogramming Tumor-Associated Macrophages To Reverse EGFR(T790M) Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat, Peng, Huige, Chen, Binfan, Huang, Wei, Tang, Yubo, Jiang, Yifan, Zhang, Wenyuan, Huang, Yongzhuo, 2017
  • Poly-γ-glutamic acid-based GGT-targeting and surface camouflage strategy for improving cervical cancer gene therapy, Tan Jiao, Wang Huiyuan, Xu Fan, 2017
  • Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance, Chen, Yingzhi, Zhang, Meng, Jin, Hongyue, Tang, Yisi, Wu, Aihua, Huang, Yongzhuo, 2017
  • Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature, Chen, Yingzhi, Zhang, Meng, Jin, Hongyue, Tang, Yisi, Wang, Huiyuan, Xu, Qin, Li, Yaping, Li, Feng, Huang, Yongzhuo, 2017
  • Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy, Zhao, Pengfei, Yin, Weimin, Wu, Aihua, Tang, Yisi, Wang, Jinyu, Pan, Zhenzhen, Lin, Tingting, Zhang, Meng, Chen, Binfan, Duan, Yifei, Huang, Yongzhuo, 2017
  • Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy, Lin, Tingting, Zhao, Pengfei, Jiang, Yifan, Tang, Yisi, Jin, Hongyue, Pan, Zhenzhen, He, Huining, Yang, Victor C, Huang, Yongzhuo, 2016
  • Nuclear-targeting TAT-PEG-Asp8-Doxorubicin Polymeric Nanoassembly for Overcoming Drug-resistant Colon Cancer, Yongzhuo Huang, 2016
  • Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy, Cui, Yanna, Zhang, Meng, Zeng, Feng, Jin, Hongyue, Xu, Qin, Huang, Yongzhuo, 2016
  • Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization, Hu, Ying, Xu, Beihua, Xu, Jiaojiao, Shou, Dan, Liu, Ergang, Gao, Jianqing, Liang, Wenquan, Huang, Yongzhuo, 2015
  • A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging, Wang, Yaping, Lin, Tingting, Zhang, Wenyuan, Jiang, Yifan, Jin, Hongyue, He, Huining, Yang, Victor C, Chen, Yi, Huang, Yongzhuo, 2015
  • Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors, Wang, Huiyuan, Jiang, Yifan, Peng, Huige, Chen, Yingzhi, Zhu, Peizhi, Huang, Yongzhuo, 2015
  • Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44(+) cancer cells, Liang, Jianming, Zeng, Feng, Zhang, Meng, Pan, Zhenzhen, Chen, Yingzhi, Zeng, Yuaner, Xu, Yong, Xu, Qin, Huang, Yongzhuo, 2015
  • Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer, Wang, Huixin, Zhao, Yongxing, Wang, Huiyuan, Gong, Junbo, He, Huining, Shin, Meong Cheol, Yang, Victor C, Huang, Yongzhuo, 2014
  • Molecular-Dynamics-Simulation-Driven Design of a Protease-Responsive Probe for In-Vivo Tumor Imaging, Jiang, Yifan, Lu, Junyan, Wang, Yaping, Zeng, Feng, Wang, Huiyuan, Peng, Huige, Huang, Min, Jiang, Hualiang, Luo, Cheng, Huang, Yongzhuo, 2014
  • Cell-Penetrating Peptide-Mediated Topical Delivery of Biomacromolecular Drugs, Tan, Jiao, Cheong, Heesun, Park, Yoon Shin, Kim, Hangun, Zhang, Meng, Moon, Cheol, Huang, Yongzhuo, 2014
  • CPP-mediated Protein Delivery in a Noncovalent Form: Proof-of-Concept for Percutaneous and Intranasal Delivery, Wang, Zhao, Chen, Yingzhi, Liu, Ergang, Gong, Junbo, Shin, Meong Cheol, Huang, Yongzhuo, 2014
  • Protease-Activatable Hybrid Nanoprobe for Tumor Imaging, Wang, Yaping, Jiang, Yifan, Zhang, Meng, Tan, Jiao, Liang, Jianming, Wang, Huixin, Li, Yaping, He, Huining, Yang, Victor C, Huang, Yongzhuo, 2014
  • Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer, Wang, Huiyuan, Li, Feng, Du, Chengan, Wang, Huixin, Mahato, Ram I, Huang, Yongzhuo, 2014
  • Cell-Penetrating Apoptotic Peptide/p53 DNA Nanocomplex as Adjuvant Therapy for Drug-Resistant Breast Cancer, Wang, Huiyuan, Wang, Huixin, Liang, Jianming, Jiang, Yifan, Guo, Qianqian, Peng, Huige, Xu, Qin, Huang, Yongzhuo, 2014
  • Curb challenges of the 'Trojan Horse' approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery, Huang, Yongzhuo, Jiang, Yifan, Wang, Huiyuan, Wang, Jianxin, Shin, Meong Cheol, Byun, Youngro, He, Huining, Liang, Yanqin, Yang, Victor C, 2013
  • Cell-Penetrating Peptide-Modified PLGA Nanoparticles for Enhanced Nose-to-Brain Macromolecular Delivery, Yan, Lu, Wang, Huiyuan, Jiang, Yifan, Liu, Jinhua, Wang, Zhao, Yang, Yongxin, Huang, Shengwu, Huang, Yongzhuo, 2013
  • Pluronic L61 as a long-circulating modifier for enhanced liposomal delivery of cancer drugs, Wang, Ye, Liu, Ergang, Sun, Xiaoyi, Huang, Pengyu, Long, Hao, Wang, Hua, Yu, Xin, Zheng, Caihong, Huang, Yongzhuo, 2013
  • Template synthesis of PMAA@chitosan hollow nanorods for docetaxel delivery, Sun, Yajuan, Dong, Weibing, Wang, Huiyuan, Huang, Yongzhuo, Gu, Huike, Yang, Victor C, Gong, Junbo, 2013
  • Co-delivery of Cell-permeable Chimeric Apoptosis AVPIR(8) Peptide/p53 DNA for Cocktail Therapy, Wang, Huiyuan, Guo, Qianqian, Jiang, Yifan, Liu, Ergang, Zhao, Yongxing, Wang, Huixin, Li, Yaping, Huang, Yongzhuo, 2013
  • Cell-penetrating albumin conjugates
Transdermal New Formulations Technologies Chemical Drugs Traditional Chinese Medicine Transdermal Vaccine Delivery Biotechnology Drug Delivery Systems Nanotechnology Tumor Imaging

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.